Procter & Gamble plans to acquire the supplements brand Thorne in a transaction valued at $3.8 billion, according to CNBC — Business. The announcement was shared by P&G CEO Shailesh Jejurikar during his appearance on the program "Squawk on the Street," where he outlined the company's objective to expand its presence within the consumer health and wellness sector.
Transaction Summary
| Attribute | Detail |
|---|---|
| Acquirer | Procter & Gamble |
| Target Brand | Thorne |
| Transaction Value | $3.8 billion |
| Announcement Date | August 4, 2026 |
The deal represents a move by the consumer goods giant to integrate Thorne’s specialized supplements portfolio into its broader health division. By absorbing Thorne, P&G seeks to capitalize on the increasing consumer demand for science-backed nutritional products. As of the announcement on August 4, 2026, the acquisition is being positioned as a growth-oriented investment for the firm.
While the official details remain subject to standard regulatory review and customary closing conditions, the company has clearly defined its trajectory for this segment of its operations. The integration of Thorne is expected to provide P&G with a deeper footprint in the preventative health market, an area that has seen consistent growth as consumers prioritize personalized wellness routines.
Why It Matters
This acquisition signals a defensive and offensive shift for traditional consumer packaged goods (CPG) companies. By moving into the premium supplement space, P&G is attempting to mitigate slowing growth in its legacy cleaning and personal care divisions. The $3.8 billion price tag suggests the company places a high premium on Thorne’s brand loyalty and direct-to-consumer data sets. For the broader industry, this consolidation indicates that large-cap conglomerates are increasingly reliant on buying high-growth health startups to maintain market relevance against agile, digitally-native wellness brands.
Reader Discussion & Insights